Sekerci, Ç. A. Et Al. 2019. Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia. JOURNAL OF UROLOGY , vol.201, no.1 , 174-180.

Sekerci, Ç. A., TANIDIR, Y., Toprak, T., Basok, B. I., Isman, F., ŞİMŞEK, F., ... Akbal, C.(2019). Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia. JOURNAL OF UROLOGY , vol.201, no.1, 174-180.

Sekerci, ÇAĞRI Et Al. "Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia," JOURNAL OF UROLOGY , vol.201, no.1, 174-180, 2019

Sekerci, ÇAĞRI A. Et Al. "Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia." JOURNAL OF UROLOGY , vol.201, no.1, pp.174-180, 2019

Sekerci, Ç. A. Et Al. (2019) . "Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia." JOURNAL OF UROLOGY , vol.201, no.1, pp.174-180.

@article{article, author={ÇAĞRI AKIN ŞEKERCİ Et Al. }, title={Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia}, journal={JOURNAL OF UROLOGY}, year=2019, pages={174-180} }